ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2026
[Prenatal ultrasound and genetic characteristics of 60 fetuses with 16p11.2 microdeletion].
Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe postnatal phenotypes of fetuses with 16p11.2 microdeletion mainly include autism spectrum disorder, schizophrenia, and intellectual disability, often accompanied by obesity and congenital malformations. However, studies on the prenatal phenotypes of fetuses with 16p11.2 microdeletion remain limited. This study aims to investigate the correlation between prenatal ultrasound findings and genetic characteristics of fetuses with 16p11.2 microdeletion, thereby providing evidence for clinical genetic counseling.
methodsClinical data of 60 fetuses prenatally diagnosed with 16p11.2 microdeletion at multiple centers between October 2016 and December 2024 were collected. Data included maternal age, indications for amniocentesis and gestational age at testing, fetal ultrasound findings, and copy number variation sequencing (CNV-seq) results. CNV-seq was also performed in both parents to determine the origin of the variants. Pregnancy outcomes were followed up for all cases. Based on prenatal ultrasound findings, genetic test results, and pregnancy outcomes, the prenatal phenotypes and genomic characteristics of fetuses with 16p11.2 microdeletion were systematically analyzed.
resultsAmong 43 721 fetuses who underwent CNV-seq testing, 60 cases of 16p11.2 microdeletion were identified (60/43721, 0.14%). Of these, 49 cases had proximal deletions (BP4-BP5), 9 had distal deletions (BP2-BP3), and 2 had large deletions (BP2-BP5). Among the 49 fetuses with proximal 16p11.2 deletions (BP4-BP5), 18 had structural abnormalities, including 6 cases of hemivertebra with scoliosis, 4 cases of renal developmental abnormalities, 2 cases of coarctation of the aorta, and 6 cases of other abnormalities. Twenty-six fetuses presented with ultrasound soft markers, including 11 cases of increased nuchal translucency (NT) thickness (1 accompanied by a single umbilical artery), 6 cases of mild ventriculomegaly (1 accompanied by polyhydramnios), and 9 cases of other soft markers. Five fetuses showed no ultrasound abnormalities. Among the 9 fetuses with distal 16p11.2 deletions (BP2-BP3), 2 had intrauterine growth restriction, 4 presented with ultrasound soft markers (2 with absent nasal bone, 1 with a single umbilical artery, and 1 with increased NT thickness), and 3 had no ultrasound abnormalities. Among the 2 fetuses with large 16p11.2 deletions (BP2-BP5), 1 presented with congenital diaphragmatic hernia and the other with increased NT thickness. Of the 50 cases, 72% (36/50) were de novo variants and 28% (14/50) were inherited from a parent. Regarding pregnancy outcomes, 67% (35/52) of pregnancies were terminated.
conclusionsPrenatal ultrasound phenotypes of fetuses with 16p11.2 microdeletion are highly heterogeneous. Proximal 16p11.2 deletions (BP4-BP5) are primarily associated with hemivertebra accompanied by scoliosis, renal developmental abnormalities, and increased NT thickness. In contrast, distal 16p11.2 deletions (BP2-BP3) may be associated with intrauterine growth restriction and ultrasound soft markers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.